SLC1A2 and Parkinson disease: They found that exosomes from PD patients with RBD had lower levels of excitatory amino acid transporters-2 (EAAT-2) and vesicular glutamate transporter type 1 (VGLUT-1), suggesting that they could be used as predictors to differentiate subtypes of PD patients [105].